Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.035
+0.045 (1.51%)
Nov 21, 2024, 1:32 PM EST - Market open
Prime Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 388 | 817 | 1,609 | - | - | - |
| Market Cap Growth | -43.35% | -49.22% | - | - | - | - |
| Enterprise Value | 247 | 669 | 1,890 | - | - | - |
| Last Close Price | 2.99 | 8.86 | 18.58 | - | - | - |
| PB Ratio | 2.01 | 6.14 | 5.09 | - | - | - |
| P/TBV Ratio | 2.60 | 6.14 | 5.09 | - | - | - |
| Debt / Equity Ratio | 0.22 | 0.10 | 0.09 | 0.04 | 0.52 | - |
| Asset Turnover | 0.00 | - | - | - | 0.16 | - |
| Quick Ratio | 6.09 | 2.16 | 11.00 | 4.65 | 2.74 | 1.18 |
| Current Ratio | 6.50 | 2.53 | 11.10 | 4.67 | 2.75 | 1.19 |
| Return on Equity (ROE) | -114.35% | -88.19% | -43.83% | -121.13% | -19.56% | - |
| Return on Assets (ROA) | -46.51% | -43.15% | -22.00% | -29.61% | -1.84% | - |
| Return on Capital (ROIC) | -60.21% | -48.63% | -24.48% | -35.09% | -2.22% | - |
| Earnings Yield | -57.47% | -24.25% | -7.57% | - | - | - |
| FCF Yield | -49.89% | -21.31% | -9.19% | - | - | - |
| Buyback Yield / Dilution | -26.37% | -168.42% | -161.23% | -391.47% | -77.53% | - |
| Total Shareholder Return | -26.37% | -168.42% | -161.23% | -391.47% | -77.53% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.